Immunome, Inc.
Hedge Funds Holdings
Last updated:
Immunome, Inc.‘s stocks are currently a part of 15 hedge funds’ portfolios, which represents 1.94% of the total amount of its stocks outstanding. This makes up a total of 235.23K shares of Immunome, Inc.. Compared to the previous quarter, the number fell by -88.79% or -1.86M shares fewer. As for the holding position changes, 26.67% (4) of current hedge fund investors increased the number of shares held, 26.67% (4) of current holders sold a part of the shares held, and 13.33% (2) closed the holdings completely. 2 hedge funds are new holders of Immunome, Inc. stock in Q1 2023, it is 13.33% of total holders.
Hedge funds holding Immunome (Q4 2020 – Q1 2023)
| Q4 2020 | 25 |
|---|---|
| Q1 2021 | 30 |
| Q2 2021 | 27 |
| Q3 2021 | 33 |
| Q4 2021 | 29 |
| Q1 2022 | 28 |
| Q2 2022 | 25 |
| Q3 2022 | 24 |
| Q4 2022 | 26 |
| Q1 2023 | 15 |
Hedge funds changes in Immunome positions (Q4 2020 – Q1 2023)
| Q4 2020 | 25 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q1 2021 | 8 | 8 | 12 | 3 | -1 |
| Q2 2021 | 11 | 8 | 6 | 14 | -12 |
| Q3 2021 | 13 | 7 | 6 | 7 | 0 |
| Q4 2021 | 6 | 12 | 2 | 10 | -1 |
| Q1 2022 | 3 | 5 | 10 | 4 | 6 |
| Q2 2022 | 3 | 3 | 7 | 6 | 6 |
| Q3 2022 | 3 | 5 | 1 | 4 | 11 |
| Q4 2022 | 4 | 4 | 7 | 2 | 9 |
| Q1 2023 | 2 | 4 | 4 | 2 | 3 |
Hedge funds changes in Immunome stock options (Q4 2020 – Q1 2023)
| Q4 2020 | 0 | 0 |
|---|---|---|
| Q1 2021 | 0 | 0 |
| Q2 2021 | 0 | 5,000 |
| Q3 2021 | 2,123,000 | 1,231,000 |
| Q4 2021 | 1,448,000 | 553,000 |
| Q1 2022 | 240,000 | 163,000 |
| Q2 2022 | 147,000 | 0 |
| Q3 2022 | 231,000 | 0 |
| Q4 2022 | 5,500 | 6,000 |
| Q1 2023 | 4,990,000 | 37,000 |